For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. If you need to see your provider, please contact us to see if a Video Visit is right for you. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
Radiation Oncology

You are here

Clinical Trials

clinical trials group photo


(last updated 04/16/2020)

Prone partial breast irradiation (PBI): Prospective randomized controlled non-inferiority trial to compare radiation fibrosis with five versus three fractions (NCT02755896) 

  • IRB # 1505016201

Accelerated Radiation Therapy (ART) To the Breast and Nodal Stations after Neo-Adjuvant Chemotherapy and Surgery: A Feasibility Study (NCT02917421)

  • IRB # 1602017017    

Radiation and immune checkpoints blockade in metastatic NSCLC (BMS # CA209-632) (NCT03168464)

  • IRB # 1607017434

Effect of radiotherapy variables on circulating effectors of immune response and local microbiome (NCT03383107)

  • IRB # 1708018471 

Pembrolizumab and Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients (NCT03449238)

  • IRB # 1710018694

PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) (NCT03663218)

  • IRB # 1712018849

 Prospective Randomized study of Accelerated Radiation Therapy (PRART) (NCT04175210)

  • IRB # 19-07020533

Converting HR+ Breast Cancer Into an Individualized Vaccine (NCT03804944)

  • IRB # 1808019498

Personalized Second Chance Breast Conservation (PSCBC): A Two Center Prospective Phase II Clinical Study

  • IRB # 19-07020531

Single-Arm Phase II Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer (PSMA SBRT-SIB)

  • IRB # 19-10020928

CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer

  • IRB # 19-09020752

PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer

  • IRB# 19-04020263

The Irradiated Breast Tumor Cavity: A Biological Hub.

  • IRB # 19-07020524

ISABR STUDY: A Multi-Site Randomized Phase I/II Study of Stereotactic Ablative Body Radiotherapy +/- MEDI 4736 (Durvalumab) for Medically Inoperable Early- Stage Non-Small Cell Lung Cancer

  • IRB # 19-04020249

Prospective phase II Study of Stereotactic MR-guided on-table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Inoperable Locally Advanced Pancreatic Cancer

  • IRB # 19-04020160


Not accepting any new patients

last updated  04/16/2020

RTOG0534: A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only RT (SPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy (NCT00567580)  

  • IRB # 0810010069 

An Open-Label Multicenter Phase 1b Study of E7046 in Combination with Radiotherapy/ Chemo radiotherapy (RT/CRT) in preoperative treatment of Subjects with Rectum Cancer (NCT03152370)

  • IRB # 1612017834

NRG GU003 - A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT) (NCT03274687)

  • IRB # 1708018460

MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer (SIBRT) (NCT03664193)

  • IRB # 1802019010

A Phase II randomized controlled trial of PD-1/PDL-1 axis blockade versus PD-1/PDL-1 axis blockade plus radiotherapy in metastatic genitourinary (renal/urothelial) malignancies (NCT03115801)

  • IRB # 1606017369   


Closed studies

last updated 12/13/2019

Randomized trial of image-guided stereotactic radiation therapy  (IG-SRT) in prostate cancer (NCT02911922)

  • IRB # 1604017139 

A First-in-Human Study of Repeat Dosing with REGN2810, a Monoclonal, Fully Human Antibody to Programmed Death - 1 (PD-1), as Single Therapy and in Combination with Other Anti-Cancer Therapies in Patients with Advanced Malignancies (NCT02383212)

  • IRB # 1505016229

LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer (NCT02538471)

  • IRB # 1505016222

Phase I/II study of TLR7 agonist Imiquimod, Cyclophosphamide, and Radiotherapy in Breast Cancer Patients with Chest Wall Recurrence or Skin Metastases (NCT01421017)

  • IRB # 1505016228


 group photo

Clinical Trials Contact Information

Stich Radiation Oncology Clinical Trials

Maria Fenton-Kerimian,N.P.
Tel: (212) 746-6074

Sharanya Chandrasekhar
Tel: (646) 962-2196

Pragya Yadav
Tel: (646) 962-2199

Vijayalakshmi Nagaraj
Tel: (646) 962-3118

Contact Us

David H. Koch Center

New York-Presbyterian Hospital/
Weill Cornell Medical Center
1283 York Avenue, 4th floor
New York, NY 10065
Tel: (212) 746-3600
View Map

Stich Radiation Oncology Center

New York-Presbyterian Hospital/
Weill Cornell Medical Center
525 East 68th Street
New York, NY 10065
Tel: (212) 746-3600
View Map

The Arnold Center For Radiation Oncology

New York Hospital Queens
56-45 Main Street
(56th Avenue between Main Street and 141st Street)
Flushing, NY 11355
Tel: (718) 670-1501

View Map

New York-Presbyterian/
Lower Manhattan Cancer Center

21 West Broadway
New York, NY 10003
Tel: (212) 746-6600

View Map